Home/Filings/4/0001140361-14-008924
4//SEC Filing

Raptor Pharmaceutical Corp 4

Accession 0001140361-14-008924

CIK 0001070698operating

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 9:40 PM ET

Size

5.4 KB

Accession

0001140361-14-008924

Insider Transaction Report

Form 4
Period: 2014-02-18
SAGER ERICH
Director
Transactions
  • Sale

    Common Stock

    2014-02-18$15.17/sh10,000$151,72384,297 total
Footnotes (2)
  • [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on August 13, 2013.
  • [F2]This transaction was executed in multiple trades at prices ranging from $15.02 to $15.42. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide, upon request, to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Documents

1 file

Issuer

Raptor Pharmaceutical Corp

CIK 0001070698

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001070698

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 9:40 PM ET
Size
5.4 KB